Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

14.36
Delayed Data
As of Aug 21
 -0.16 / -1.10%
Today’s Change
5.24
Today|||52-Week Range
15.58
+97.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues21.7M23.8M27.6M35.6M
 
 
 
 
 
Cost of Goods Sold647.0K546.0K633.0K766.0K
 
 
 
 
 
Depreciation And Amortization21.0K15.0K13.0K9.0K
 
 
 
 
 
 
Operating ExpensesGross Income21.1M23.3M27.0M34.8M
 
 
 
 
 
General Expenses18.0M18.2M22.2M22.0M
 
 
 
 
 
Research And Development7.1M6.5M7.2M7.9M
 
 
 
 
 
Total Operating Expenses18.7M18.8M22.9M22.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income3.1M5.0M4.7M12.8M
 
 
 
 
 
Interest Expense On Debt455.0K367.0K270.0K149.0K
 
 
 
 
 
Other Expenses-32.0K-42.0K45.0K51.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.6M4.6M4.5M12.7M
 
 
 
 
 
Income Taxes0.000.00-127.0K-50.0K
 
 
 
Net Income2.6M4.6M4.4M12.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS110.7M111.9M112.9M113.2M
 
 
 
 
 
Shares To Calculate EPS Diluted116.4M118.9M121.2M123.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02$0.04$0.04$0.10
 
 
 
 
 
EPS Diluted$0.02$0.04$0.04$0.10